封面
市场调查报告书
商品编码
1642364

日本的近红外线成像市场评估:产品·用途·终端用户·各地区的机会及预测 (2018-2032年)

Japan Near-Infrared Imaging Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, FY2018-FY2032F

出版日期: | 出版商: Market Xcel - Markets and Data | 英文 139 Pages | 商品交期: 3-5个工作天内

价格

日本近红外线成像市场规模预计将从 2024 年的 1.1609 亿美元增长到 2032 年的 1.8006 亿美元,预测期内的复合年增长率为 5.64%。由于癌症、心血管疾病和神经系统疾病等慢性疾病的发病率不断上升,以及对先进成像技术的需求不断增加,预计日本近红外线成像市场将在预测期内实现强劲增长。

近红外线成像是一种不可见成像技术,利用近红外光观察组织和物体内部的结构功能和活动。先进的影像解决方案可以改善诊断和治疗结果。人工智慧和先进萤光剂的加入等技术发展几乎提高了红外线以外视觉化系统的性能,使其得以在各种医疗保健应用中实施。此外,近红外线成像在微创和影像导引手术(尤其是肿瘤学和重建手术)中的应用越来越多,正在推动市场成长。例如,2024年3月,Artience株式会社推出了Sciforiem FI系列,这是一种先进的近红外线萤光探针,可用于对细胞和外泌体进行高灵敏度成像。这些探针具有快速、生动的染色、高萤光强度和优异的光稳定性。

本报告提供日本的近红外线成像的市场调查,彙整市场定义和概要,市场规模的转变·预测,各种区分的详细分析,影响市场成长因素的分析,案例研究,竞争情形,主要企业简介等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 日本的近红外线成像市场展望

  • 市场规模的分析·预测
  • 市场占有率的分析·预测
    • 各产品
    • 各用途
    • 各终端用户
    • 各地区
    • 企业占有率分析(前五名公司以及其他)
  • 市场地图分析

第5章 供需分析

第6章 价值链分析

第7章 波特的五力分析

第8章 大环境分析

第9章 价格分析

第10章 市场动态

  • 推动市场要素
  • 市场课题

第11章 市场趋势·展开

第12章 法规结构和革新

  • 法规当局的认证
  • 革新

第13章 专利的形势

第14章 案例研究

第15章 竞争情形

  • 前五名公司的竞争矩阵
  • 前五名公司的SWOT分析
  • 前十大企业的形势
    • Carl Zeiss Meditec AG
    • Shimadzu Corporation
    • Stryker Corporation.
    • Olympus Corporation.
    • Hamamatsu Photonics K.K.
    • Medtronic plc

第16章 策略性建议

第17章 关于调查公司·免责声明

Product Code: MX12637

Japan near-infrared imaging (NIR) market is projected to witness a CAGR of 5.64% during the forecast period FY2025-FY2032, growing from USD 116.09 million in FY2024 to USD 180.06 million in FY2032. The near-infrared imaging market in Japan is expected to grow robustly during the forecast period owing to the rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders, and increased demand for advanced imaging technologies.

Near-infrared imaging is an invisible imaging technique that uses near-infrared light to view the structural function and activity inside the tissue or objects. Moreover, advanced imaging solutions can improve diagnostic and treatment outcomes. With technological developments such as artificial intelligence and the addition of advanced fluorescent agents, the performance of the visualization system is almost improved in infrared form, and implementation in various healthcare applications is supplied. Additionally, the increased utilization of NIR imaging in minimally invasive and image-guided surgeries, especially in oncology and reconstructive procedures, is driving market growth. For instance, in March 2024, Artience Co., Ltd. announced the Sciforiem FI Series, advanced near-infrared fluorescence probes, for high-sensitivity imaging of cells and exosomes. These probes offer fast, vivid staining, high fluorescence intensity, and superior photostability.

Rising Demand for Non-Invasive Diagnostics for Chronic and Age-Related Diseases

The growing demand for non-invasive diagnostic solutions for treating chronic and age-related diseases is a key driver for the growth of the near-infrared imaging market in Japan. Japan's aging population leads to an increase in the prevalence of diseases such as cancer, cardiovascular diseases, and neurological disorders, thereby increasing the need for advanced imaging technologies that provide accurate real-time information without the risks associated with invasive procedures. NIR imaging's ability to visualize biological tissues safely, painlessly, and in detail makes it an attractive option for early diagnosis and monitoring, facilitating easy implementation in clinical and research settings. This trend is expected to continue to drive market expansion as healthcare providers favor patient-centric, minimally invasive diagnostic approaches. For instance, a study published in the Anticancer Research Journal evaluated the feasibility of combining near-infrared photoimmunotherapy with immune checkpoint inhibitor therapy for unresectable recurrent head and neck cancer. Conducted at Ryukyu University Hospital, the study included five patients, four of whom received NIR-PIT combined with pembrolizumab. A 100% best-observed response rate was achieved among seven treated lesions, with three complete and four partial responses.

Advancements in Imaging Technologies Drive Market Growth

Advances in imaging technologies are major growth drivers for the Japan near-infrared imaging market. Incorporating cutting-edge innovations such as artificial intelligence, improved fluorescence agents, and high-resolution sensors greatly enhanced NIR imaging systems' accuracy, sensitivity, and real-time capabilities. Technological advances allow for more accurate diagnostics, especially in complex medical applications such as oncology, neurology, and cardiovascular imaging. Portable and low-cost solutions for NIR imaging are bringing the market within the reach of different settings, including hospitals and point-of-care facilities. Therefore, the prospects of this technology further improve the demands for NIR imaging as the advancement in imaging technology progresses. For instance, in October 2024, e-con Systems Inc. launched the See3CAM_CU83, a 4K RGB-IR superspeed USB camera featuring onsemi's AR0830 sensor. This innovative camera captures both RGB and infrared images simultaneously, making it suitable for various applications such as biometric access control, in-cabin monitoring, crop health monitoring, image-guided surgeries, and smart patient monitoring.

Near-Infrared Devices Segment to Dominate the Near-Infrared Imaging Market

The near-infrared devices segment is expected to capture the maximum market share in the near-infrared imaging market, led by extensive use across sectors such as health care, manufacturing, and agriculture, which can make this possible. It is encompassed by cameras, sensors, and even systems with high-quality capabilities in real-time analysis, non-invasive diagnostics, and material inspection. Its applications in health care are highly in demand nowadays as a better diagnostic tool for chronic diseases and surgical guidance. Meanwhile, industries use NIR devices for quality control and defect control. Ongoing technological advancements in this segment, including improved sensitivity and portability, are expected to maintain market leadership and will continue contributing to market growth. For instance, in August 2024, Shimadzu Corporation launched the LuminousQuester NI, a near-infrared imaging system designed to enhance drug discovery research. This system features a camera that simultaneously captures near-infrared and visible light and dedicated software for nonclinical applications.

Preclinical Imaging Segment to Dominate the Near-Infrared Imaging Market

The preclinical imaging segment is expected to dominate the Japan near-infrared imaging market, with rising demand for advanced imaging solutions primarily in drug discovery, disease modeling, and preclinical research expected to drive market growth. Near-infrared imaging is a high-resolution, non-invasive, real-time technique for visualizing biological processes. As such, they play an important role in early-stage research for evaluating treatment efficacy and monitoring disease progression. Their high sensitivity and specificity in tracking molecular and cellular activity enhance their utility in preclinical research, especially in the areas of oncology, neurology, and cardiovascular research. The demand for efficient and accurate preclinical imaging technologies, especially with pharmaceutical and biotechnology companies continuing to focus on developing novel therapeutics, will propel significant growth in this segment. For instance, in October 2021, MILabs B.V. introduced its 7 Series Integrated Line of products, enhancing user experience by improving the performance of individual imaging modalities and their integration. The new system reveals molecular images previously obscured by noise, enabling advanced applications such as SPECT to PET translation, fluorescence and bioluminescence tomography, and targeted radiotherapy with high-energy tracers.

Future Market Scenario (FY2025-FY2032F)

Continuous innovations in miniaturized, high-resolution NIR imaging systems will push the adoption of these applications into medical, industrial, and scientific use.

Growing usage in healthcare, food inspection, environmental monitoring, and semiconductor testing is going to open up wider markets.

The demand for NIR imaging in medical applications like tissue imaging and surgical guidance is increasing due to the increased needs of healthcare, which are driven by the aging population and by a focus on precision diagnostics.

Strong governmental support and investments in research and development are fostering innovation and market growth.

The market is going to be more competitive in nature, where the focus will be on product differentiation, customization, and localized solutions to meet industry-specific demands.

Key Players Landscape and Outlook

Japan near-infrared imaging market is shaped by strategic initiatives such as mergers, acquisitions, and collaborations among key players, driving innovation and growth. Regulatory approvals for new products further enhance market expansion, positioning NIR imaging for continued development and increased adoption across various sectors.

For instance, in February 2024, Hamamatsu Photonics K.K. introduced the C16741-40U, a high-performance InGaAs camera with sensitivity from 400 nm to 1700 nm, spanning visible to SWIR regions. Due to minimized readout noise, it delivers high-resolution imaging with an exceptional signal-to-noise ratio. Integrated Peltier cooling ensures sensor stability, while the USB 3.1 Gen 1 interface supports 12-bit imaging and adjustable exposure times. Designed for food sorting, plastic recycling, silicon wafer inspection, laser alignment, and solar cell evaluation.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Near-Infrared Imaging Market Outlook, FY2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Devices
        • 4.2.1.1.1. Near-infrared Fluorescence Imaging Systems
        • 4.2.1.1.2. Near-infrared Fluorescence and Bioluminescence Imaging Systems
      • 4.2.1.2. Reagents
        • 4.2.1.2.1. Indocyanine Green (ICG)
        • 4.2.1.2.2. Other Reagents
    • 4.2.2. By Application
      • 4.2.2.1. Preclinical Imaging
      • 4.2.2.2. Cardiovascular Surgeries
      • 4.2.2.3. Gastrointestinal Surgeries
      • 4.2.2.4. Cancer Surgeries
      • 4.2.2.5. Plastic/Reconstructive Surgeries
      • 4.2.2.6. Others
    • 4.2.3. By End-user
      • 4.2.3.1. Hospitals and Clinics
      • 4.2.3.2. Pharmaceutical and Biotechnology Companies
      • 4.2.3.3. Research Laboratories
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Central
      • 4.2.4.3. South
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
  • 4.3. Market Map Analysis, FY2024
    • 4.3.1. By Product
    • 4.3.2. By Application
    • 4.3.3. End-user
    • 4.3.4. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

  • 10.1. Market Drivers
  • 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

  • 12.1. Regulatory Approvals
  • 12.2. Innovations

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

  • 15.1. Competition Matrix of Top 5 Market Leaders
  • 15.2. SWOT Analysis for Top 5 Players
  • 15.3. Key Players Landscape for Top 10 Market Players
    • 15.3.1. Carl Zeiss Meditec AG
      • 15.3.1.1. Company Details
      • 15.3.1.2. Key Management Personnel
      • 15.3.1.3. Products and Services
      • 15.3.1.4. Financials (As Reported)
      • 15.3.1.5. Key Market Focus and Geographical Presence
      • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 15.3.2. Shimadzu Corporation
    • 15.3.3. Stryker Corporation.
    • 15.3.4. Olympus Corporation.
    • 15.3.5. Hamamatsu Photonics K.K.
    • 15.3.6. Medtronic plc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Japan Near-Infrared Imaging Market, By Value, In USD Million, FY2018-FY2032F
  • Figure 2. Japan Near-Infrared Imaging Market Share (%), By Product, FY2018-FY2032F
  • Figure 3. Japan Near-Infrared Imaging Market Share (%), By Application, FY2018-FY2032F
  • Figure 4. Japan Near-Infrared Imaging Market Share (%), By End-user, FY2018-FY2032F
  • Figure 5. Japan Near-Infrared Imaging Market Share (%), By Region, FY2018-FY2032F
  • Figure 6. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
  • Figure 7. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
  • Figure 8. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
  • Figure 9. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024